Now Hiring

AmebaGone is looking for some great people to join the company! We're hiring for BS/MS-level technician roles and PhD-level Scientist roles. We're especially interested in those with plant pathology backgrounds.
If you are passionate about working with a bleeding-edge technology, excited about startup culture, and ready to make a big impact, please apply!


Mark Benedyk, Ph.D.

Executive Director

Image of Mark Benedyk, Ph.D.

Dr. Benedyk is President & CEO of Telephus Medical, a company dedicated to developing innovative immunotherapies to treat antibiotic-resistant bacterial infections. He is also Senior Advisor to Sweetwater Capital Partners, a private equity firm in Encinitas, California. Dr. Benedyk is a Director at Accel-Rx, Canada’s national health sciences accelerator and at Pulmotect Inc., in Houston, Texas, a clinical-stage company focused on developing next-generation therapies to treat pulmonary infections.  He is also an Advisor to RARE Science, a non-profit focused on applying genomics to accelerate cures for children with rare diseases.

Previously, he was Senior Director and head of The Pfizer Incubator LLC (TPI). Dr. Benedyk has held executive Business Development positions at Ascenta Therapeutics, Optimer Pharmaceuticals (now Merck NYSE: MRK), Aurora Biosciences (acquired by Vertex Pharmaceuticals NASDAQ: VRTX), and Elan Pharmaceuticals (now Perrigo NYSE: PRGO). He received his Ph.D. in Developmental Genetics from The Rockefeller University, where he was a Lucille P. Markey Graduate Fellow and his B.S. degree in Microbiology and Botany from the University of Michigan.

Marcin Filutowicz, Ph.D.

Founder, President, CSO

Image of Marcin Filutowicz, Ph.D.

Dr. Marcin Filutowicz, founded AmebaGone, Inc. in 2010 to commercialize a novel technology based upon the unique potential of free-living professional phagocytes (Dictyostelids or Dicty), found in soil and many other environments worldwide, to combat disease-causing microbes in affecting plants, water quality and human health.

Dr. Filutowicz and Katarzyna Borys from the Bacteriology Department of University of Wisconsin-Madison conceived the core technology. The inventors have assigned title for their work to AmebaGone and have executed a license to a collection of source material amassed by Dr. Kenneth Raper (also UW-Madison) with the Wisconsin Alumni Research Foundation (WARF). Filutowicz has developed biocontrol countermeasures to reduce infections caused by antibiotic-resistant bacteria since 1999. Dr. Filutowicz is a serial innovator, having co-founded ConjuGon Inc. in 2001 after inventing its technology. ConjuGon (now Atterx Biotherapeutics) is developing therapeutics to treat human bacterial infections. ConjuGon raised over $18M to advance its technology and is currently in Phase III clinical trials.

Dr. Filutowicz is a Professor of Bacteriology at University of Wisconsin-Madison where he joined the faculty in 1987 and has since been continuously funded. He received his Ph.D from the Polish Academy of Sciences.

Amy Jancewicz, Ph.D.

Agricultural R&D Lead Scientist

Image of Amy Jancewicz, Ph.D.

Dr. Amy Jancewicz, Ph.D., joined Amebagone to contribute understanding of plant growth behaviors and the molecular mechanisms that govern them.  Amy received her PhD in Cellular and Molecular Biology from the University of Wisconsin-Madison, and comes to AmebaGone with over a decade of research experience. In addition to her contributions at the bench as the agricultural research lead, Amy makes substantial contributions to AmebaGone's operations as a business strategist.

Courtney Trinastic

Lead Research Specialist

Image of Courtney Trinastic

Courtney Trinastic joined Amebagone in 2017.  She holds a B.S. in Microbiology from the University of Wisconsin-Madison.  While studying for her degree, Courtney worked in Dr. Marcin Filutowicz’s lab in the Department of Bacteriology at UW-Madison, where she led a project to revive a source collection of Dicty along with researching interactions between Dicty and various biofilms. Courtney's mentoring and biosafety experience, lab management skills, and meticulous work style have resulted in her becoming a major contributor in the lab. Additionally, Courtney has become a key leader of operations.

Kristi Freibergs

Research Specialist

Image of Kristi Freibergs

Kristi Freibergs joined Amebagone as a lab technician in 2017 to work on revitalizing a source collection of Dicty.  She currently attends the University of Wisconsin-Madison where she is working toward her B.S. in Microbiology. While working in Dr. Marcin Filutowicz’s lab at the Department of Bacteriology in UW-Madison, Kristi contributed to the revitalization of a second Dicty collection and mentored several undergraduate students. Additionally, she researched the development of Dicty during their predation of bacteria.